London, United Kingdom –News Direct– Elsevier
Growing demand for healthcare workers and medical education, accelerated by the COVID-19 pandemic, drives the need for digital health education solutions
Osmosis’s highly engaging visual learning offerings will be applied to other areas of Elsevier’s healthcare portfolio
Elsevier, a global leader in research publishing and information analytics, today announced the acquisition of Osmosis, a US-based visual learning platform that has simplified the journey complex learning experience for millions of current and future healthcare professionals and their patients around the world.
There is still a growing need for healthcare professionals and medical training, which has been accelerated by the COVID-19 pandemic. Osmosis uses the science of evidence-based learning to create distinct microcontent that turns complex medical concepts into easy-to-follow learning modules. With a broad reach in 195 countries, Osmosis has more than two million subscribers on its YouTube channel, more than 150 partnerships with institutions ranging from medical schools to digital health companies, and more than a quarter of a billion views. of its content.
Osmosis will join Elsevier’s Global Medical Education portfolio, complementing its advanced digital solutions, which enable students and healthcare professionals to learn and apply complex health information more effectively. Elsevier intends to enhance other segments of healthcare with the effective microcontent capabilities provided by Osmosis, including meeting the learning needs of medical students and healthcare professionals, nursing students. and, possibly, patients.
Shiv Gaglani, Co-Founder and CEO of Osmosis, said, “The first health education materials I used in medical school were Elsevier’s signature resources, Grey’s Anatomy and Net. The Osmosis team and I are honored to join Elsevier given its incredible global impact on health education and training, our cultural alignment and strong commitments, and its unprecedented legacy stretching back over 140 years. . We are excited about this next chapter working with the Elsevier team to empower tens of millions of current and future healthcare professionals and their patients around the world.
Elsevier’s extensive healthcare education offerings include content, digital learning tools and analytics for medical and nursing students to prepare them for successful careers in the healthcare professions .
Elizabeth Munn, Managing Director and Managing Director, Global Medical Education, Elsevier, said, “We are delighted to welcome the Osmosis team to Elsevier and to continue to deliver on our promise to support students throughout their career. learning, thereby improving outcomes in health care. . Osmosis has created an amazing team, a winning culture and a portfolio of premier health education solutions. We look forward to advancing our mission together.
The Osmosis acquisition follows Elsevier’s other acquisitions in nursing and health education, including Shadow Health, a developer of virtual nursing simulations, and 3D4 Medical, creator of the Complete Anatomy app, an advanced 3D anatomy platform with AR / VR capabilities.
Jan Herzhoff, President, Health at Elsevier, said: “Our mission is to improve every patient outcome today and in the future by helping clinicians make better decisions and improving learning outcomes for patients. future health professionals. We believe in the power of visualization and look forward to bringing together the breadth and depth of Elsevier with the innovative and highly engaging learning solutions offered by Osmosis to support the next generation of healthcare leaders.
Click here to watch the announcement video.
Osmosis.org is a health education platform that provides millions of current and future clinicians and caregivers with the best possible learning experience. As a pioneer in health education technology, Osmosis pushes learning beyond textbooks and lectures by delivering simple, engaging and informative online educational video content. Osmosis.org has a library of over 2,100 videos covering pathology, physiology, pharmacology and clinical practice, with questions, cards and notes. For more information, visit www.osmose.org.
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating knowledge and critical decision-making for clients in the global research and health ecosystems.
In everything we publish, we hold ourselves to the highest standards of quality and integrity. We bring the same rigor to our information analysis solutions for researchers, health professionals, institutions and funders.
Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for over 140 years. Stemming from our roots in publishing, we offer valuable knowledge and analysis that help our users to make inroads and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support and health education. Researchers and healthcare professionals rely on our 2,500+ digital journals, including The Lancet and Cell; our 40,000 electronic book titles; and our iconic reference books, such as Grey’s Anatomy. With the Elsevier Foundation and our External Inclusion and Diversity Advisory Board, we work in partnership with various stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries. And in the world.
Elsevier is part of RELX, a global provider of information-based analysis and decision tools for professional and business clients. www.elsevier.com
RELX is a global provider of information-based analysis and decision tools for professional and business clients. The group serves clients in more than 180 countries and has offices in approximately 40 countries. It employs more than 30,000 people, nearly half of them in North America. Shares of RELX PLC, the parent company, trade on the London, Amsterdam and New York stock exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalization is around 44.8 billion pounds sterling, 53 billion euros, 59.7 billion dollars. www.relx.com
Teresa Mueller, Vice President, Global Health Markets
+31 20 485 2719
See the source version on newsdirect.com: https://newsdirect.com/news/elsevier-acquires-osmosis-org-an-innovative-digital-health-education-platform-and-enhances-its-global-medical-education – wallet-817636934